Home LiteratureArticle Details
PMID: 8898364 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.

Molecular biology of the cell ·Vol. 7 ·No. 10 ·1996-10-00 ·Pages 1587-99

Franklin DS, Xiong Y

Abstract

Terminal cell differentiation involves permanent withdrawal from the cell division cycle. The inhibitors of cyclin-dependent kinases (CDKs) are potential molecules functioning to couple cell cycle arrest and cell differentiation. In murine C2C12 myoblast cells, G1 CDK enzymes (CDK2, CDK4, and CDK6) associate with four CDK inhibitors: p18INK4c, p19INK4d, p21, and p27Kip1. During induced myogenesis, p21 and its associated CDK proteins underwent an initial increase followed by a decrease as cells became terminally differentiated. The level of p27 protein gradually increased, but the amount of total associated CDK proteins remained unchanged. p19 protein decreased gradually during differentiation, as did its associated CDK4 protein. In contrast, p18 protein increased 50-fold, from negligible levels in proliferating myoblasts to clearly detectable levels within 8-12 h of myogenic induction. This initial rise was followed by a precipitous increase between 12 and 24 h postinduction, with p18 protein finally accumulating to its highest level in terminally differentiated cells. Induction of p18 correlated with increased and sequential complex formation--first increasing association with CDK6 and then with CDK4 over the course of myogenic differentiation. All of the CDK6 and half of the CDK4 were complexed with p18 in terminally differentiated C2C12 cells as well as in adult mouse muscle tissue. Finally, kinase activity of CDK2 and CDK4 decreases as C2C12 cells differentiate, whereas the CDK6 kinase activity is low in both proliferating myoblasts and differentiated myotubes. Our results indicate that p18 may play a critical role in causing and/or maintaining permanent cell cycle arrest associated with mature muscle formation.

MeSH Terms
Amino Acid Sequence Carrier Proteins/genetics,metabolism Cell Cycle Proteins Cell Differentiation/genetics Cell Division Cyclin-Dependent Kinase 4 Cyclin-Dependent Kinase 6 Cyclin-Dependent Kinase Inhibitor p18 Cyclin-Dependent Kinases/metabolism Enzyme Inhibitors Gene Expression Regulation, Developmental Humans Molecular Sequence Data Muscle Proteins/genetics,metabolism Muscle, Skeletal/cytology,metabolism Organ Specificity Protein Serine-Threonine Kinases/metabolism Proto-Oncogene Proteins Tumor Suppressor Proteins
Chemicals
CDKN2C protein, human Carrier Proteins Cell Cycle Proteins Cyclin-Dependent Kinase Inhibitor p18 Enzyme Inhibitors Muscle Proteins Proto-Oncogene Proteins Tumor Suppressor Proteins Protein Serine-Threonine Kinases CDK4 protein, human CDK6 protein, human Cyclin-Dependent Kinase 4 Cyclin-Dependent Kinase 6 Cyclin-Dependent Kinases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Franklin D S
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina 27599, USA.
Xiong Y
References (60)
60 references, click to expand
  1. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.
    Nature. 1977 Dec 22-29;270(5639):725-7 PMID: 563524
  2. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
    Genes Dev. 1995 Mar 15;9(6):639-49 PMID: 7729683
  3. Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.
    J Cell Biol. 1987 Aug;105(2):949-56 PMID: 3624313
  4. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.
    Cell. 1989 Feb 24;56(4):607-17 PMID: 2537150
  5. Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5.
    Genes Dev. 1992 May;6(5):888-902 PMID: 1315706
  6. A family of human cdc2-related protein kinases.
    EMBO J. 1992 Aug;11(8):2909-17 PMID: 1639063
  7. Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein.
    Mol Biol Cell. 1992 Oct;3(10):1107-15 PMID: 1421568
  8. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.
    Cell. 1992 Oct 16;71(2):323-34 PMID: 1423597
  9. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA.
    Cell. 1992 Oct 30;71(3):505-14 PMID: 1358458
  10. SV40 large T inhibits myogenic differentiation partially through inducing c-jun.
    J Biochem. 1992 Sep;112(3):321-9 PMID: 1331038
  11. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein.
    Oncogene. 1993 Feb;8(2):267-78 PMID: 8381218
  12. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.
    Cell. 1993 Feb 12;72(3):309-24 PMID: 8381715
  13. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.
    Genes Dev. 1993 Aug;7(8):1572-83 PMID: 8101826
  14. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication.
    Cell. 1993 Sep 24;74(6):979-92 PMID: 8402887
  15. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.
    Mol Cell Biol. 1995 May;15(5):2672-81 PMID: 7739547
  16. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.
    Mol Cell Biol. 1995 May;15(5):2682-8 PMID: 7739548
  17. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Genes Dev. 1995 May 15;9(10):1149-63 PMID: 7758941
  18. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
    Nature. 1995 Jun 8;375(6531):503-6 PMID: 7777060
  19. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition.
    Nature. 1995 Jun 8;375(6531):506-10 PMID: 7777061
  20. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.
    Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5451-5 PMID: 7777529
  21. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation.
    Mol Cell Biol. 1995 Jul;15(7):3823-9 PMID: 7791789
  22. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Science. 1995 Aug 4;269(5224):682-5 PMID: 7624798
  23. Inhibition of cyclin-dependent kinases by p21.
    Mol Biol Cell. 1995 Apr;6(4):387-400 PMID: 7626805
  24. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
    Genes Dev. 1995 Mar 15;9(6):650-62 PMID: 7729684
  25. Cloning and characterization of murine p16INK4a and p15INK4b genes.
    Oncogene. 1995 Aug 17;11(4):635-45 PMID: 7651726
  26. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.
    Cell. 1995 Aug 25;82(4):675-84 PMID: 7664346
  27. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
    Genomics. 1995 Oct 10;29(3):623-30 PMID: 8575754
  28. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.
    Genes Dev. 1996 Jan 15;10(2):142-53 PMID: 8566748
  29. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein.
    Genes Dev. 1996 Apr 1;10(7):804-15 PMID: 8846917
  30. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.
    Science. 1996 May 3;272(5262):719-22 PMID: 8614832
  31. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
    Cell. 1996 May 31;85(5):707-20 PMID: 8646779
  32. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).
    Cell. 1996 May 31;85(5):721-32 PMID: 8646780
  33. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
    Cell. 1996 May 31;85(5):733-44 PMID: 8646781
  34. Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.
    Mol Biol Cell. 1996 Jan;7(1):57-70 PMID: 8741839
  35. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  36. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  37. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes.
    Mol Biol Cell. 1993 Sep;4(9):897-906 PMID: 7903056
  38. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  39. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Nature. 1993 Dec 16;366(6456):704-7 PMID: 8259215
  40. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.
    Nature. 1993 Dec 16;366(6456):707-10 PMID: 8259216
  41. The MyoD family and myogenesis: redundancy, networks, and thresholds.
    Cell. 1993 Dec 31;75(7):1241-4 PMID: 8269506
  42. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
    Mol Cell Biol. 1994 Mar;14(3):2077-86 PMID: 8114739
  43. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.
    Exp Cell Res. 1994 Mar;211(1):90-8 PMID: 8125163
  44. A cell cycle regulator potentially involved in genesis of many tumor types.
    Science. 1994 Apr 15;264(5157):436-40 PMID: 8153634
  45. Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells.
    Exp Cell Res. 1994 Jun;212(2):297-307 PMID: 8187822
  46. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells.
    Science. 1994 Jun 3;264(5164):1467-71 PMID: 8197461
  47. C2C12 cells: biophysical, biochemical, and immunocytochemical properties.
    Am J Physiol. 1994 Jun;266(6 Pt 1):C1795-802 PMID: 8023908
  48. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Cell. 1994 Jul 15;78(1):59-66 PMID: 8033212
  49. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Cell. 1994 Jul 15;78(1):67-74 PMID: 8033213
  50. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
    Oncogene. 1994 Aug;9(8):2261-8 PMID: 7913544
  51. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
    Nature. 1994 Sep 15;371(6494):257-61 PMID: 8078588
  52. G1 phase progression: cycling on cue.
    Cell. 1994 Nov 18;79(4):551-5 PMID: 7954821
  53. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
    Cell. 1994 Nov 18;79(4):573-82 PMID: 7954824
  54. p21-containing cyclin kinases exist in both active and inactive states.
    Genes Dev. 1994 Aug 1;8(15):1750-8 PMID: 7958854
  55. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Genes Dev. 1994 Dec 15;8(24):2939-52 PMID: 8001816
  56. A variant form of cyclin-dependent kinase 2 (Cdk2) in a malignantly transformed rat thyroid (FRTL-Tc) cell line.
    Oncogene. 1995 Feb 16;10(4):663-9 PMID: 7862443
  57. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
    Science. 1995 Feb 17;267(5200):1018-21 PMID: 7863327
  58. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.
    Science. 1995 Feb 17;267(5200):1024-7 PMID: 7863329
  59. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal.
    Curr Opin Cell Biol. 1994 Dec;6(6):788-94 PMID: 7880524
  60. Heterokaryon analysis of muscle differentiation: regulation of the postmitotic state.
    J Cell Biol. 1987 Aug;105(2):937-47 PMID: 3624312
Article Info
Journal
Molecular biology of the cell
Abbr.
Mol Biol Cell
ISSN
1059-1524
Published
1996-10-00
Pages
1587-99
Language
English
Region
United States
NLM ID
9201390
PMCID
PMC276008
Subset
IM
Grants
NCI NIH HHS · CA-65572 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]